Last year, Penumbra Inc generated 947.92M USD for its biggest-performing segment, Thrombectomy. The United States made the largest contribution, accounting for 1.09B USD last year. For the latest quarter, Penumbra Inc reported the revenue of 258.98M USD for the period ending 2026-06-30, which came from the top-performing segment, Thrombectomy. United States contributed the highest revenue, at 305.44M USD.

By Business

Revenue

Proportion

Annual

Annual

Quarterly

Thrombectomy

Embolization and Access

FY2025

FY2024

FY2023

FY2022

FY2021

FY2020

FY2019

Thrombectomy

947.92M(67.53%)

815.48M(68.26%)

677.34M(63.99%)

499.39M(58.95%)

408.88M(54.69%)

267.78M(47.78%)

215.72M(39.41%)

Embolization and Access

455.75M(32.47%)

379.14M(31.74%)

381.18M(36.01%)

347.74M(41.05%)

338.71M(45.31%)

292.63M(52.22%)

331.69M(60.59%)

By Region

Revenue

Proportion

Annual

Annual

Quarterly

United States

International

Japan

FY2025

FY2024

FY2023

FY2022

FY2021

FY2020

FY2019

FY2018

FY2017

FY2016

FY2015

FY2014

FY2013

United States

1.09B(77.78%)

902.07M(75.51%)

757.15M(71.53%)

591.72M(69.85%)

527.79M(70.60%)

400.27M(71.42%)

355.22M(64.89%)

290.72M(65.34%)

219.17M(65.67%)

176.10M(66.88%)

127.31M(68.41%)

82.97M(66.10%)

58.30M(65.62%)

International

311.90M(22.22%)

292.55M(24.49%)

301.37M(28.47%)

255.42M(30.15%)

219.80M(29.40%)

160.14M(28.58%)

149.66M(27.34%)

112.42M(25.27%)

80.80M(24.21%)

56.93M(21.62%)

39.77M(21.37%)

27.85M(22.19%)

17.88M(20.12%)

Japan

--(--)

42.52M(7.77%)

41.80M(9.40%)

33.79M(10.12%)

30.28M(11.50%)

19.02M(10.22%)

14.70M(11.71%)

12.67M(14.26%)